| 释义 |
- References
- Further reading
{{Multiple issues|{{Underlinked|date=March 2018}}{{Orphan|date=March 2018}}
}}{{Infobox_gene}}Cytoskeleton regulator RNA is a protein that in humans is encoded by the CYTOR gene. CYTOR plays a role in breast cancer. It regulates genes involved in the EGFR/mammalian target of rapamycin pathway and is required for cell proliferation, cell migration, and cytoskeleton organization.[1] [2] References 1. ^{{cite journal|last1=Van Grembergen|first1=Olivier|title=Portraying breast cancer with long non coding RNA|journal=Science Advances|date=2016|doi=10.1126/sciadv.1600220}}
2. ^{{cite web| title = Entrez Gene: Cytoskeleton regulator RNA| url = https://www.ncbi.nlm.nih.gov/gene/112597| accessdate = 2017-09-04}}
Further reading {{refbegin | 2}}- {{cite journal |vauthors=Van Grembergen O, Bizet M, de Bony EJ, Calonne E, Putmans P, Brohée S, Olsen C, Guo M, Bontempi G, Sotiriou C, Defrance M, Fuks F |title=Portraying breast cancers with long noncoding RNAs. |journal=Sci Adv |volume=2 |issue=9 |year=2016 |doi=10.1126/sciadv.1600220 |pmid=27617288}}
- {{cite journal |vauthors=Pang Q, Ge J, Shao Y, Sun W, Song H, Xia T, Xiao B, Guo J |title=Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance |journal=Tumour Biol. |volume=35 |issue=6 |pages=5441–7 |year=2014 |pmid=24523021 |doi=10.1007/s13277-014-1709-3 |url=}}
- {{cite journal |vauthors=Tani H, Onuma Y, Ito Y, Torimura M |title=Long non-coding RNAs as surrogate indicators for chemical stress responses in human-induced pluripotent stem cells |journal=PLoS ONE |volume=9 |issue=8 |pages=e106282 |year=2014 |pmid=25171338 |pmc=4149554 |doi=10.1371/journal.pone.0106282 |url=}}
- {{cite journal |vauthors=Zhao J, Liu Y, Zhang W, Zhou Z, Wu J, Cui P, Zhang Y, Huang G |title=Long non-coding RNA Linc00152 is involved in cell cycle arrest, apoptosis, epithelial to mesenchymal transition, cell migration and invasion in gastric cancer |journal=Cell Cycle |volume=14 |issue=19 |pages=3112–23 |year=2015 |pmid=26237576 |pmc=4825539 |doi=10.1080/15384101.2015.1078034 |url=}}
- {{cite journal |vauthors=Li J, Wang X, Tang J, Jiang R, Zhang W, Ji J, Sun B |title=HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma |journal=Cell. Physiol. Biochem. |volume=37 |issue=2 |pages=687–96 |year=2015 |pmid=26356260 |doi=10.1159/000430387 |url=}}
- {{cite journal |vauthors=Zhou J, Zhi X, Wang L, Wang W, Li Z, Tang J, Wang J, Zhang Q, Xu Z |title=Linc00152 promotes proliferation in gastric cancer through the EGFR-dependent pathway |journal=J. Exp. Clin. Cancer Res. |volume=34 |issue= |pages=135 |year=2015 |pmid=26538117 |pmc=4632266 |doi=10.1186/s13046-015-0250-6 |url=}}
- {{cite journal |vauthors=Ji J, Tang J, Deng L, Xie Y, Jiang R, Li G, Sun B |title=LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway |journal=Oncotarget |volume=6 |issue=40 |pages=42813–24 |year=2015 |pmid=26540343 |pmc=4767473 |doi=10.18632/oncotarget.5970 |url=}}
- {{cite journal |vauthors=Chen WM, Huang MD, Sun DP, Kong R, Xu TP, Xia R, Zhang EB, Shu YQ |title=Long intergenic non-coding RNA 00152 promotes tumor cell cycle progression by binding to EZH2 and repressing p15 and p21 in gastric cancer |journal=Oncotarget |volume=7 |issue=9 |pages=9773–87 |year=2016 |pmid=26799422 |pmc=4891083 |doi=10.18632/oncotarget.6949 |url=}}
- {{cite journal |vauthors=Yue B, Cai D, Liu C, Fang C, Yan D |title=Linc00152 Functions as a Competing Endogenous RNA to Confer Oxaliplatin Resistance and Holds Prognostic Values in Colon Cancer |journal=Mol. Ther. |volume=24 |issue=12 |pages=2064–2077 |year=2016 |pmid=27633443 |doi=10.1038/mt.2016.180 |url=}}
- {{cite journal |vauthors=Hu HB, Jie HY, Zheng XX |title=Three Circulating LncRNA Predict Early Progress of Esophageal Squamous Cell Carcinoma |journal=Cell. Physiol. Biochem. |volume=40 |issue=1-2 |pages=117–125 |year=2016 |pmid=27855375 |doi=10.1159/000452529 |url=}}
{{refend}}{{gene-2-stub}} |